Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Pfizer Inc (PFE)

Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

Covered Call Screener Results for April 7th

Covered calls are a great strategy to add to any portfolio, and can offer enhanced yield from stock holdings, in some case, that can be a significant increase.

To trade a covered call we need to own (or buy) 100 shares of a stock and then sell a call option against that stock position.

Fundamentals

See More
  • Market Capitalization, $K 158,248,832
  • Shares Outstanding, K 5,686,268
  • Annual Sales, $ 62,579 M
  • Annual Income, $ 7,771 M
  • EBIT $ 19,118 M
  • EBITDA $ 25,710 M
  • 60-Month Beta 0.43
  • Price/Sales 2.57
  • Price/Cash Flow 6.44
  • Price/Book 1.86

Options Overview Details

View History
  • Implied Volatility 29.69% (+1.19%)
  • Historical Volatility 23.39%
  • IV Percentile 88%
  • IV Rank 33.74%
  • IV High 52.17% on 04/10/25
  • IV Low 18.25% on 08/18/25
  • Expected Move (DTE 3) 0.57 (2.09%)
  • Put/Call Vol Ratio 1.92
  • Today's Volume 78,188
  • Volume Avg (30-Day) 104,247
  • Put/Call OI Ratio 0.83
  • Today's Open Interest 2,377,783
  • Open Int (30-Day) 2,547,676
  • Expected Range 26.63 to 27.77

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 28 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $0.77
  • Number of Estimates 7
  • High Estimate $0.92
  • Low Estimate $0.64
  • Prior Year $0.92
  • Growth Rate Est. (year over year) -16.30%

Price Performance

See More
Period Period Low Period High Performance
1-Month
26.35 +2.54%
on 03/09/26
28.75 -5.98%
on 04/02/26
-0.02 (-0.09%)
since 03/06/26
3-Month
24.97 +8.21%
on 01/13/26
28.75 -5.98%
on 04/02/26
+1.74 (+6.90%)
since 01/07/26
52-Week
20.92 +29.21%
on 04/09/25
28.75 -5.98%
on 04/02/26
+4.40 (+19.42%)
since 04/07/25

Most Recent Stories

More News
Covered Call Screener Results for April 7th

Covered calls are a great strategy to add to any portfolio, and can offer enhanced yield from stock holdings, in some case, that can be a significant increase.

XLE : 60.62 (+1.58%)
OXY : 63.63 (+1.06%)
CSCO : 80.19 (-0.30%)
PFE : 27.02 (-2.91%)
BP : 47.71 (+0.48%)
2 Healthcare Stocks for Long-Term Investors and 1 We Ignore

2 Healthcare Stocks for Long-Term Investors and 1 We Ignore

EHC : 106.01 (+0.82%)
THC : 192.28 (+1.05%)
PFE : 27.02 (-2.91%)
2 Reasons to Watch PFE and 1 to Stay Cautious

2 Reasons to Watch PFE and 1 to Stay Cautious

PFE : 27.02 (-2.91%)
Trump unveils 100% tariff on some patented drugs on 'Liberation Day' anniversary

President Donald Trump has signed an executive order that could slap long-threatened pharmaceutical tariffs of up to 100% on some patented drugs from companies that don’t reach deals with his administration...

PFE : 27.02 (-2.91%)
Pfizer Invites Public to View and Listen to Webcast of May 5 Conference Call with Analysts

Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10:00 a.m. EDT on Tuesday, May 5, 2026. The purpose of...

PFE : 27.02 (-2.91%)
5 High-Yield Stocks to Shield Your Portfolio From the Storm

With the S&P 500 breaking below its 200-day SMA, high-yield dividend stocks are increasingly worth considering as a source of income and portfolio protection.

VZ : 48.96 (-0.39%)
BTI : 59.16 (+0.77%)
KHC : 23.33 (-1.02%)
MPLX : 55.72 (+0.11%)
SPY : 654.24 (-0.71%)
PFE : 27.02 (-2.91%)
Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 VALOR Trial

Vaccine candidate PF-07307405 (LB6V) demonstrated more than 70% efficacy in preventing Lyme disease in individuals aged five years and above The investigational...

VALN : 5.85 (-1.85%)
PFE : 27.02 (-2.91%)
2 Unpopular Stocks That Should Get More Attention and 1 We Avoid

2 Unpopular Stocks That Should Get More Attention and 1 We Avoid

TER : 313.70 (-0.55%)
BHF : 60.07 (-0.13%)
PFE : 27.02 (-2.91%)
Pfizer Recommends Shareholders Reject the Mini-Tender Offer by Tutanota LLC

Pfizer Inc. (NYSE: PFE) today announced that it has received notice of an unsolicited mini-tender offer by Tutanota LLC (“Tutanota”) to purchase up to 1 million shares of Pfizer common stock at a price...

PFE : 27.02 (-2.91%)
Follow the Footprints: 3 Stocks with Unusual Options Activity That You Can’t Ignore

On a day when nothing worked for investors, yesterday’s unusual options activity had plenty of variety, especially in the top three. Here’s how investors might have played each of the stock's and their...

ADI : 322.66 (-1.44%)
MCHP : 66.30 (-1.37%)
IVZ : 22.70 (-0.79%)
PFE : 27.02 (-2.91%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength just crossed below 50%. The market is indicating support for a bearish trend.

See More Share

Business Summary

Pfizer Inc. is a research-based, global biopharmaceutical company. The company boasts a sustainable pipeline with multiple late-stage programs that can drive growth. Pfizer markets a wide range of drugs and vaccines. Its business comprises six business units - Oncology, Inflammation & Immunology, Rare...

See More

Key Turning Points

3rd Resistance Point 28.52
2nd Resistance Point 28.38
1st Resistance Point 28.10
Last Price 27.02
1st Support Level 27.68
2nd Support Level 27.54
3rd Support Level 27.26

See More

52-Week High 28.75
Last Price 27.02
Fibonacci 61.8% 25.75
Fibonacci 50% 24.83
Fibonacci 38.2% 23.91
52-Week Low 20.92

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.